Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : SNY    crawled date : 2021 - 07 - 01    save search

Regeneron Genetics Center Discovers GPR75 Gene Mutations that Protect Against Obesity
Published: 2021-07-01 (Crawled : 21:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%
REGN | $898.33 -0.7% -0.71% 650K twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 3.65% C: 3.24%
ALNY | $147.775 -0.49% -0.49% 490K twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 0.21% C: 0.03%

obesity genetic
COVID-19 Highlights Need for Kidney Treatment Innovation
Published: 2021-07-01 (Crawled : 20:00) - prnewswire.com
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 0.0% C: 0.0%
CDNA 4 | $8.21 -3.75% -3.9% 610K twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.6% C: -2.18%

covid treatment covid-19 kidney
FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
Published: 2021-07-01 (Crawled : 17:02) - fda.gov
PRGO A | $30.13 -0.63% 0.0% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.48% H: 2.41% C: 2.37%
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%

fda
Adhesion Barriers Market to Ride on the Back of Rising Need to Address Post-operative Complications, Market to Exhibit Steady Growth at 7% CAGR during 2019 to 2027
Published: 2021-07-01 (Crawled : 16:00) - prnewswire.com
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%

growth
Global Roundup: Astellas and FibroGen Receive Positive CHMP Opinion for CKD Drug
Published: 2021-07-01 (Crawled : 14:00) - biospace.com/
AKYA | $4.02 -2.66% -2.74% 150K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.1% H: 4.55% C: -1.66%
ZEAL | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
| | O: -0.89% H: 0.89% C: 0.07%
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%
FGEN | $1.3 -4.41% -4.62% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.19% C: -1.01%

positive drug chmp
Global Mobile Medical Apps Market to Reach $16.5 Billion by 2026
Published: 2021-07-01 (Crawled : 13:15) - prnewswire.com
ARVL | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -0.06% H: 1.6% C: -0.45%
NVS | $94.41 0.95% 0.0% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.5% C: 0.39%
MDT | $80.23 0.13% 0.2% 6.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 1.39% C: 1.34%
GSK | $40.5 -0.39% -0.03% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 1.18% C: 0.53%
BMY | $48.51 0.48% 0.0% 12M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.48% C: 0.21%
BSX | $67.44 -0.93% 0.0% 6.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 1.71% C: 1.36%
ABT | $108.89 -0.2% 0.04% 4.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 1.45% C: 1.34%
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%
AZN | $68.75 -0.26% -0.26% 7.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 0.95% C: 0.73%

mobile
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-01 (Crawled : 13:13) - fda.gov
LLY | $750.77 -0.12% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.0% H: 0.87% C: 0.71%
BMY | $48.51 0.48% 0.0% 12M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.48% C: 0.21%
ADCT | $4.37 -0.46% 0.0% 460K twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 2.35% C: 1.86%
YMAB | $14.91 3.76% 3.62% 300K twitter stocktwits trandingview |
Health Technology
| | O: 0.24% H: 3.9% C: 3.69%
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%
REGN | $898.33 -0.7% -0.71% 650K twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 3.65% C: 3.24%
KPTI | $1.155 -5.33% -5.63% 810K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.0% C: 3.0%
INCY | $53.42 -0.8% -0.8% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 0.49% C: -0.08%
EPZM | $1.47 -1.34% 0.0% twitter stocktwits trandingview |
Health Technology
| | O: 0.84% H: 1.67% C: 0.95%
CLVS | $0.0812 -3.94% twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.9% C: 0.0%
BPMC | $85.19 -2.36% -2.42% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.67% C: -0.34%
AVEO | $15.0 0.0% 0 twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 0.0% C: -5.55%

cancer approval
DiNAQOR Expands Board of Directors with Three Renowned Cardiovascular Industry and Academic Experts
Published: 2021-07-01 (Crawled : 13:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%

cardiovascular cardio
Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel
Published: 2021-07-01 (Crawled : 12:00) - prnewswire.com
WINT | $0.4249 -2.32% -2.38% 100K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.31% C: -0.87%
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%


MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO
Published: 2021-07-01 (Crawled : 12:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%

ceo leo
EQRx Appoints Carlos Garcia-Echeverria, Ph.D., as Chief of Rx Creation
Published: 2021-07-01 (Crawled : 12:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%


XNK Therapeutics Reports First Patient Included in Phase II Study in Multiple Myeloma
Published: 2021-07-01 (Crawled : 07:00) - prnewswire.com
SNY | $46.22 0.63% 0.63% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.36% C: 0.08%


Gainers vs Losers
49% 51%

Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M twitter stocktwits trandingview |
Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M twitter stocktwits trandingview |
Health Technology

DYNT | $0.371 -5.12% 43.09% 3.3M twitter stocktwits trandingview |
Health Technology

LGVN P 3 d | $2.94 73.96% 42.52% 57M twitter stocktwits trandingview |

HUBC | $1.94 49.23% 32.99% 73M twitter stocktwits trandingview |
n/a

SPCB | $0.4044 46.52% 31.75% 130M twitter stocktwits trandingview |
Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M twitter stocktwits trandingview |
Health Technology

OMQS | $0.6869 32.1% 24.3% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...

SNPO | $10.555 29.67% 22.88% 4M twitter stocktwits trandingview |

AMBI | $3.72 -26.77% 21.77% 9.8K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.